Belatacept in renal transplantation in comparison to tacrolimus and molecular understanding of resistance pattern:Meta-analysis and systematic review

Jayant Kumar; Isabella Reccia; Francesco Virdis; Mauro Podda; Ajay Kumar Sharma; Ahmed Halawa

文献导航

搜索文章

搜索思路

钛学术文献服务平台 \
学术期刊 \
综合期刊 \
其它期刊 \
世界移植杂志期刊 \
Belatacept in renal transplantation in comparison to tacrolimus and molecular understanding of resistance pattern:Meta-analysis and systematic review

Belatacept in renal transplantation in comparison to tacrolimus and molecular understanding of resistance pattern:Meta-analysis and systematic review

作者：

Jayant Kumar Isabella Reccia Francesco Virdis Mauro Podda Ajay Kumar Sharma Ahmed Halawa

基本信息来源于合作网站，原文需代理用户跳转至来源网站获取

Adverse

events

Calcineurin

inhibitors

BELATACEPT

TACROLIMUS

Graft

failure

Kidney

transplantation

摘要：

BACKGROUND The T-cell costimulation blocking agent belatacept has been identified as a possible substitute for calcineurin inhibitors,however,no consensus has been established against its use over the standard care agent Tacrolimus.AIM To evaluate the effectiveness of belatacept based maintenance immunosuppressive regimens in comparison to tacrolimus in renal transplantion.METHODS We did extensive search of all the available literature comparing the role of belatacept to tacrolimus in renal transplant recipients by searching the PubMed,Embase,Cochrane,Crossref,Scopus,clinical trials registry on October 5,2020.RESULTS The literature search identified four randomized controlled trials(n=173 participants)comparing belatacept with tacrolimus.There was no significant difference in estimated renal function at 12 mo[mean difference 4.12 mL/min/1.73 m^(2),confidence interval(CI):-2.18 to 10.42,P=0.20].Further,belatacept group was associated with significant increase in biopsy proven acute rejection[relative risk(RR)=3.27,CI:0.88 to 12.11,P=0.08]and worse 12 mo allograft survival(RR=4.51,CI:1.23 to 16.58,P=0.02).However,incidence of new onset diabetes mellitus was lower with belatacept at 12 mo(RR=0.26,CI:0.07 to 0.99,P=0.05).CONCLUSION The evidence reviewed in this meta-analysis suggested that belatacept-based maintenance immunosuppression regimens were associated with an increased risk allograft loss in renal transplant recipients with equivalent renal functioning against standard tacrolimus;however,observed significantly reduced new onset diabetes mellitus after transplantation incidence and lower serum low density lipid profile levels in belatacept group.In addition,the adaptation of belatacept in renal transplantation has been forestalled by increased rates of rejection and resistance owing to development of various effector memory T cells through,parallel differentiation and immunological plasticity.

内容分析

关键词云

关键词热度

相关文献

推荐文献

根据相关规定，获取原文需跳转至原文服务方进行注册认证身份信息

完成下面三个步骤操作后即可获取文献，阅读后请点击下方页面【继续获取】按钮

钛学术文献服务平台

学术出版新技术应用与公共服务实验室出品

原文合作方

获取文献流程

1.访问原文合作方请等待几秒系统会自动跳转至登录页，首次访问请先注册账号，填写基本信息后，点击【注册】

2.注册后进行实名认证，实名认证成功后点击【返回】

3.检查邮箱地址是否正确，若错误或未填写请填写正确邮箱地址，点击【确认支付】完成获取，文献将在1小时内发送至您的邮箱

*若已注册过原文合作方账号的用户，可跳过上述操作，直接登录后获取原文即可

点击【获取原文】按钮，跳转至合作网站。

首次获取需要在合作网站进行注册。

注册并实名认证，认证后点击【返回】按钮。

确认邮箱信息，点击【确认支付】，订单将在一小时内发送至您的邮箱。

* 若已经注册过合作网站账号，请忽略第二、三步，直接登录即可。

期刊分类
期刊（年）
期刊（期）
期刊推荐

其它

世界移植杂志2021 世界移植杂志2020

世界移植杂志2021年第3期世界移植杂志2021年第2期世界移植杂志2021年第1期

按字母查找期刊：

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
其他

联系合作广告推广: shenyukuan@paperpass.com

篇名	Belatacept in renal transplantation in comparison to tacrolimus and molecular understanding of resistance pattern:Meta-analysis and systematic review
来源期刊	世界移植杂志	学科	医学
关键词	Adverse events Calcineurin inhibitors BELATACEPT TACROLIMUS Graft failure Kidney transplantation
年，卷（期）	2021,（3）	所属期刊栏目
研究方向		页码范围	70-86
页数	17页	分类号	R97
字数		语种
DOI